Today is Saturday, Sep. 19, 2020

Department of Internal Medicine

Immunology, Allergy and Rheumatology

Photo of Priyanka Vashisht

Priyanka Vashisht

Clinical Interest

Internal Medicine


Internal Medicine

  • M.D.: Maulana Azad Medical College
  • Dermatology Resident: Delhi University
  • General Practice Resident: LNR Foundation School
  • Internal Medicine Resident: Creighton University
  • Rheumatology Fellow: University of Nebraska
Board Certifications & Licenses
  • American Board of Internal Medicine 08/15/2012
  • American Board of Internal Medicine (Rheumatology) 10/13/2016
Contact Information

Peer Reviewed Publications

Onuorah, Nneoma; Abraham, Hrudya; Vashisht, Priyanka 2020. The Diagnostic Conundrum of Felty Syndrome and T-Cell Large Granular Lymphocytic Leukemia. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, ,

Vashisht, Priyanka; O'dell, James 2017. Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differences. Expert opinion on biological therapy, 17 8, 989-999

Vashisht P.;Sayles H.;Cannella A.;Mikuls T.;Michaud K. 10-01-2016. Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical Trials Arthritis Care and Research, 68 10, 1478-1488

Wampler Muskardin T.;Vashisht P.;Dorschner J.M.;Jensen M.A.;Chrabot B.S.;Kern M.;Curtis J.R.;Danila M.I.;Cofield S.S.;Shadick N.;Nigrovic P.A.;St Clair E.W.;Bingham C.O.;Furie R.;Robinson W.;Genovese M.;Striebich C.C.;O'Dell J.R.;Thiele G.M.;Moreland L.W.;Levesque M.;Bridges S.L.;Gregersen P.K.;Niewold T.B. 10-01-2016. Increased pretreatment serum IFN-?/? ratio predicts non-response to tumour necrosis factor ? inhibit Annals of the rheumatic diseases, 75 10, 1757-1762

Vashisht P.;Borghoff K.;O'Dell J.;Hearth-Holmes M. 07-01-2017. Belimumab for the treatment of recalcitrant cutaneous lupus Lupus, 26 8, 857-864

Vashisht P.;Casale T. 01-01-2013. Omalizumab for treatment of allergic rhinitis Expert Opinion on Biological Therapy, 13 6, 933-945